Design and Rationale of the GAUSS-2 Study Trial: A Double-Blind, Ezetimibe-Controlled Phase 3 Study of the Efficacy and Tolerability of Evolocumab ( AMG145) in Subjects With Hypercholesterolemia Who Are Intolerant of Statin Therapy

CLINICAL CARDIOLOGY

WILEY

1. Amgen Inc
2. Amgen
3. Eli Lilly
4. Abbott
5. Pfizer
6. Bristol-Myers Squibb
7. AstraZeneca
8. Merck Sharp
9. Dohme
10. Sanofi-Aventis
11. Pfizer Australia
12. LipoScience
13. Novartis
14. Sanofi
15. Regeneron
16. Sticares
17. InterACT
18. Boehringer Ingelheim
19. Santaris
20. Isis Pharmaceuticals
21. Merck